A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane fluidity modulator

Cellular Microbiology

Volumn 9, Issue 1, 2007, Pages 196-203

  Harada, Shinji ^a   Yokomizo, Kazumi ^b   Monde, Kazuaki ^a   Maeda, Yosuke ^a   Yusa, Keisuke ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SOJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FATTIVIRACIN FV 8; GLYCOLIPID;

ANTIVIRAL ACTIVITY; ARTICLE; CELL MEMBRANE; CELL MEMBRANE FLUIDITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG ISOLATION; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; STREPTOMYCETACEAE; VIRUS INFECTIVITY;

ANIMALS; CELL FUSION; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; DRUG EVALUATION, PRECLINICAL; GLYCOLIPIDS; GLYCYRRHIZIC ACID; HIV FUSION INHIBITORS; HIV-1; HUMANS; MEMBRANE FLUIDITY;

HUMAN IMMUNODEFICIENCY VIRUS 1; STREPTOMYCINEAE;

EID: 33845399649     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2006.00781.x     Document Type: Article

References (20)

1. Colman, P.M., and Lawrence, M.C. (2003) The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol 4: 309-319.
2. Gibbons, D.L., Erk, I., Reilly, B., Navaza, J., Kielian, M., Rey, F.A., and Lepault, J. (2003) Visualization of the target-membrane-inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography. Cell 114: 573-583.
3. Gibbons, D.L., Vaney, M., Roussel, A., Vigouroux, A., Reilly, B., Lepault, J., et.al. (2004) Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 427: 320-325.
4. Habib, E.E., Yokomizo, K., Nagao, K., Harada, S., and Uyeda, M. (2001) Antiviral activity of fattiviracin FV-8 against human immunodeficiency virus type 1 (HIV-1). Biosci Biotechnol Biochem 65: 683-685.
5. Harada, S. (2005) The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope. Biochem J 392: 191-199.
6. Harada, S., Koyanagi, Y., and Yamamoto, N. (1985) Infection of HTLV-III/ LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
7. Harada, S., Akaike, T., Yusa, K., and Maeda, Y. (2004a) Adsorption and infectivity of human immunodeficiency virus type 1 are modified by the fluidity of the plasma membrane for multiple-site binding. Microbiol Immunol 48: 347-355.
8. Harada, S., Yusa, K., and Maeda, Y. (2004b) Heterogeneity of envelope molecules shown by different sensitivities to anti-V3 neutralizing antibody and CXCR4 antagonist regulates the formation of multiple-site binding of HIV-1. Microbiol Immunol 48: 357-365.
9. Harada, S., Yusa, K., Monde, K., Akaike, T., and Maeda, Y. (2005) Influence of membrane fluidity on human immunodeficiency virus type 1 entry. Biochem Biophys Res Commun 329: 480-486.
10. Kimpton, J., and Emerman, M. (1992) Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 66: 2232-2239.
11. Leikina, E., Delanoe-Ayari, H., Melikov, K., Cho, M., Chen, A., Waring, A.J., et.al. (2005) Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol 6: 995-1001.
12. McDonald, D., Wu, L., Bohks, S.M., Kewal Ramani, V.N., Unutmaz, D., and Hope, T.J. (2003) Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300: 1295-1297.
13. Modis, Y., Ogata, S., Clements, D., and Harrison, S.C. (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427: 313-319.
14. Plonsky, I., and Zimmerberg, J. (1996) The initial fusion pore induced by baculovirus gp64 is large and forms quickly. J Cell Biol 135: 1831-1839.
15. Roche, S., and Gaudin, Y. (2002) Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers. Virology 297: 128-135.
16. Song, W., Yahara, S., Maeda, Y., Yusa, K., Tanaka, Y., and Harada, S. (2001) Enhanced infection of an X4 strain of HIV-1 due to capping and colocalization of CD4 and CXCR4 induced by capsianoside G, a diterpene glycoside. Biochem Biophys Res Commun 283: 423-429.
17. 2 I. Production, isolation, physico-chemical properties and biological activity. J Antibiot 45: 1467-1471.
18. 2 I. Structure determination. J Antibiot 45: 1472-1480.
19. Uyeda, M., Yokomizo, K., Miyamoto, Y., and Habib, E.E. (1998) Fattiviracin A1, a novel antiherpetic agent produced by streptomyces microflavus strain, 2445, I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation. J Antibiot 51: 823-828.
20. Yokomizo, K., Miyamoto, Y., Nagao, K., Kumagae, E., Habib, E.E., Suzuki, K., et.al. (1998) Fattiviracin A1, a novel antiherpetic agent produced by streptomyces microflavus strain, 2445, II. Biological properties. J Antibiot 51: 1035-1039.